The 1-[(isopropoxycarbonyl)oxy]ethyl (proxetil) ester prodrug of cefpodoxime. After swallowing, hydrolysis of the ester group occurs in the intestinal epithelium, to release active cefpodoxime in the bloodstream. It is used to treat acute otitis media, pharyngitis, and sinusitis.
Stars
This entity has been manually annotated by the ChEBI Team.
A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug.
cefpodoxime proxetil
(CHEBI:3505)
has functional parent
4-{((R)-2-Carboxy-3-methoxymethyl-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-en-7-ylcarbamoyl)-[(Z)-methoxyimino]-methyl}-thiazol-2-yl-ammonium
(CHEBI:417636)
cefpodoxime proxetil
(CHEBI:3505)
has functional parent
cefpodoxime
(CHEBI:3504)
cefpodoxime proxetil
(CHEBI:3505)
has role
antibacterial drug
(CHEBI:36047)
cefpodoxime proxetil
(CHEBI:3505)
has role
prodrug
(CHEBI:50266)
cefpodoxime proxetil
(CHEBI:3505)
is a
carboxylic acid
(CHEBI:33575)
cefpodoxime proxetil
(CHEBI:3505)
is a
carboxylic ester
(CHEBI:33308)
cefpodoxime proxetil
(CHEBI:3505)
is a
cephalosporin
(CHEBI:23066)